-59%

est. 2Y upside i

HealthcareAI & MLSeries A

We are on a mission to make healthcare personalized, accessible and easier for all of us as consumers. Our Intelligent Personalization Layer enables leading healthcare organizations and payers build deeper and richer connections with their members, driving engagement, satisfaction and improved outcomes.

Rank

#446

Sector

HealthTech, Artificial Intelligence

Est. Liquidity

~5Y

Data Quality

Data: Medium

RadiantGraph presents a strong upside opportunity driven by its exceptional growth (1400% in one year) and proven customer impact in the rapidly expanding HealthTech AI market.

Last updated: March 10, 2026

Bull (28%)+350%

RadiantGraph's AI Voice Studio and strong customer ROI (12x program enrollment, 3x surgery avoidance) drive continued hyper-growth, pushing revenue to $100M+ by 2027 and justifying a $270M+ valuation as a market leader in AI-driven health personalization.

Base (44%)+100%

RadiantGraph successfully expands its platform and customer base, achieving $50M in revenue by 2027. This steady growth leads to an acquisition or Series B round at a $120M valuation, providing a solid return on current equity.

Bear (28%)-80%

Dominant incumbents like Epic and Oracle Cerner integrate advanced AI personalization into their EHRs, commoditizing RadiantGraph's niche. Stalled growth and increased competition lead to a down round valuing the company at $12M, with the $16M liquidation preference wiping out most common stock value.

Est. time to liquidity~5.0 years

Preference Stack Risk

high

Investors hold $16M in liquidation preferences ahead of common shareholders. In an exit at or below the assumed $60M valuation, common shareholders would receive value only after the $16M is paid out to preferred shareholders.

Dilution Risk

high

As a Series A company, RadiantGraph will likely need several more funding rounds (Series B, C, etc.) before a liquidity event, which will lead to significant dilution for early equity holders.

Secondary Liquidity

none

As an early-stage private company, there is no active secondary market or tender offers for RadiantGraph shares.

Executive — 1 role

View all 1 open roles at RadiantGraph →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on RadiantGraph's data — designed to show you've done your homework.

  • 1

    “How is RadiantGraph planning to differentiate its AI personalization platform to mitigate the medium incumbent threat from large EHR players like Epic and Oracle Cerner, especially as they integrate more AI capabilities?”

  • 2

    “Given the impressive 1400% growth and strong customer ROI metrics, what are the key strategies for scaling revenue to $100M+ by 2027, and how will the company manage the associated operational challenges?”

  • 3

    “As a Series A company with a high preference stack, what is the anticipated timeline and strategy for a liquidity event, and how does the company plan to manage future dilution for employees holding common stock?”

Community

Valuation Sentiment

Our model estimates -59% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

0/2000

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.